abiraterone has been researched along with heme in 3 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (heme) | Trials (heme) | Recent Studies (post-2010) (heme) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 19,086 | 115 | 4,781 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| DeVore, NM; Petrunak, EM; Porubsky, PR; Scott, EE | 1 |
| Hu, J; Shen, H; Song, D; Sun, Z; Wang, Y; Wen, X; Xu, S; Xu, Y; Zhang, J | 1 |
| Filippova, TA; Kuzikov, AV; Masamrekh, RA; Sherbakov, KA; Shumyantseva, VV; Veselovsky, AV | 1 |
3 other study(ies) available for abiraterone and heme
| Article | Year |
|---|---|
Structures of human steroidogenic cytochrome P450 17A1 with substrates.
Topics: 17-alpha-Hydroxyprogesterone; Androstenes; Androstenols; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Dehydroepiandrosterone; Estrogens; Heme; Humans; Hydrogen Bonding; Kinetics; Models, Molecular; Molecular Structure; Mutation; Oxidation-Reduction; Pregnenolone; Progesterone; Protein Binding; Protein Structure, Secondary; Steroid 17-alpha-Hydroxylase; Steroids; Substrate Specificity; Testosterone | 2014 |
Comparative study of the binding mode between cytochrome P450 17A1 and prostate cancer drugs in the absence of haem iron.
Topics: Androstadienes; Androstenes; Antineoplastic Agents; Benzimidazoles; Binding Sites; Catalytic Domain; Cytochrome P-450 CYP1A1; Heme; Humans; Hydrophobic and Hydrophilic Interactions; Iron; Male; Molecular Docking Simulation; Prostatic Neoplasms; Protein Conformation, alpha-Helical | 2019 |
[The interactions of abiraterone and its pharmacologically active metabolite D4A with cytochrome P450 2C9 (CYP2C9)].
Topics: Androstenes; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Heme; Humans; Iron; Male; Prostatic Neoplasms | 2022 |